Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma

NCT03526679 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Leiomyosarcoma
Liposarcoma
Soft Tissue Sarcoma Adult
Advanced Cancer

Interventions

DRUG: Eribulin
DRUG: Lenvatinib

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]